Bone Grafting Materials: Autologous, Allogeneic, Xenogeneic and Alloplastic Compared

The choice of grafting material is among the most debated decisions in regenerative implantology, and also one where personal conviction weighs more heavily than evidence. Understanding the biological properties of each category allows selection based on the defect rather than on habit.

Three properties define a grafting material's behaviour. OSTEOGENESIS is the capacity to contain living cells able to form new bone: only freshly harvested autologous bone possesses it. OSTEOINDUCTION is the capacity to stimulate host mesenchymal cells to differentiate into osteoblasts, mediated by growth factors such as bone morphogenetic proteins. OSTEOCONDUCTION is the capacity to act as a scaffold for bone growth advancing from surrounding surfaces.

Autologous bone, harvested from the same patient, is the only material possessing all three properties and is for this reason considered the absolute reference. Intraoral donor sites include the mandibular symphysis, the mandibular ramus and the maxillary tuberosity; larger volumes require the iliac crest, with hospital admission and significantly higher morbidity.

Its limitations are, however, substantial and often underestimated. Harvesting involves a second surgical site with pain, swelling and risk of paraesthesia — at the symphysis, altered incisor sensitivity is reported in up to thirty per cent of cases. Available quantity is limited. And above all resorption is unpredictable: onlay block grafts lose on average between twenty and forty per cent of volume in the first six months.

Allogeneic bone, of human origin from a tissue bank, retains osteoconductive properties and — in demineralised preparations — some osteoinductivity. It eliminates the second surgical site and has no quantity limits. In Italy its use is less widespread than elsewhere for regulatory and cultural reasons, but clinical documentation is extensive and health controls on banks are rigorous.

Xenogeneic bone, of animal and in the vast majority of cases bovine origin, is the most widely used material in implantology worldwide. Deproteinisation removes the organic component leaving the mineral scaffold, whose porous structure is chemically similar to human bone. It is purely osteoconductive: it contains neither cells nor growth factors.

Its most relevant characteristic is also the most misunderstood: extremely slow resorption, with particles still histologically recognisable years later. This is often presented as a limitation, but in most indications it is an advantage: the material maintains volume over time, counteracting the resorption that afflicts autologous grafts.

Alloplastic materials are synthetic, and principally comprise calcium phosphates — hydroxyapatite and beta-tricalcium phosphate — and bioactive glasses. The advantage is unlimited availability and the absence of any risk of biological transmission. The practical difference between the two phosphates lies in resorption rate: hydroxyapatite is highly stable, beta-tricalcium phosphate resorbs within six to eighteen months leaving space for newly formed bone.

Material choice should follow defect morphology rather than operator preference. In CONTAINED defects — extraction sockets, multi-wall defects, the maxillary sinus — residual bone walls provide both mechanical stability and osteogenic cells. Here a purely osteoconductive material suffices, and xenogeneic bone represents the best-documented choice.

In NON-CONTAINED defects — narrow ridges, vertical defects, extensive dehiscences — the walls that guide regeneration are absent. Materials with greater biological capacity are needed, typically mixtures of autologous and xenogeneic bone, combined with membranes and often with space-maintaining devices. It is in these indications that the autologous component retains an irreplaceable role.

Maxillary sinus augmentation deserves specific mention as the indication with the most robust evidence. Systematic reviews show implant survival rates equivalent across autologous, xenogeneic, alloplastic materials and their mixtures — and even with clot alone in osteotome techniques with sufficient residual height. The sinus is a highly contained defect, surrounded by vascularised bone walls: the material acts as a simple space maintainer.

Particle size influences the result more than is generally considered. Small particles, below 300 micrometres, offer greater contact surface but tend to compact, reducing space for vascularisation. Large particles, above one millimetre, leave ample space but reduce contact area. The range between 250 and 1000 micrometres is the most widely used and documented.

Membranes complete the picture and their function is often misconstrued: they add no regenerative capacity, they prevent the epithelium — which migrates far faster than bone cells — from invading the space intended for regeneration. Resorbable collagen membranes are adequate in contained defects; non-resorbable titanium-reinforced ones are needed where space must be maintained against soft tissue pressure.

Membrane exposure is the most frequent complication and must be managed according to type. An exposed resorbable membrane can sometimes be retained with close monitoring and chlorhexidine; an exposed non-resorbable one must be removed, because bacterial colonisation of the surface compromises the entire regeneration.

The factor most influencing the outcome is not, however, the material but vascularisation. A graft receives nourishment from surrounding bone walls and periosteum: decorticating the recipient surface to open marrow channels, and ensuring tension-free closure, affects the result more than the choice between one product and another.

In conclusion, no material is superior in absolute terms. Xenogeneic bone covers most indications with the broadest documentation; autologous bone remains necessary in non-contained defects; alloplastic materials offer a valid alternative where patient preference excludes materials of biological origin. The difference between a good and a mediocre result depends far more on surgical technique and soft tissue management than on the product chosen.